1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Axillary clearance and chemotherapy rates in ER+HER2− breast cancer : secondary analysis of the SENOMAC trial
(
- Contribution to journal › Article
-
Mark
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases
(
- Contribution to journal › Article
-
Mark
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment : a post-hoc analysis of the randomised, phase 3 SENOMAC trial
(
- Contribution to journal › Article